Cardiovascular risk factors in people with different genotypes in the insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE)

Clinical Genetics

Volumn 52, Issue 6, 1997, Pages 422-426

  Berge, K E ^a   Berg, K ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiotensin I converting enzyme (ACE); Genetics; Insertion deletion polymorphism; Level genes; Lp(a) lipoprotein; MI risk factors; Variability genes

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE INSERTION; GENE LOCUS; GENOTYPE; HEART INFARCTION; HUMAN; PRIORITY JOURNAL;

EID: 0031424423     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1997.tb02562.x     Document Type: Article

References (26)

1. Badenhop RF, Wang XL, Wilcken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995: 91: 1655-1658.
2. Berg K. A new serum type system in man - the Lp system. Acta Pathol Microbiol Scand 1963: 59: 369-382.
3. Berg K. Twin studies of coronary heart disease and its risk factors. Acta Genet Med Gemellol 1984: 33: 349-361.
4. Berg K. Lp(a) lipoprotein: a monogenic risk factor for cardio-vascular disease. In: Goldbourt U, de Faire U, Berg K, eds. Genetic factors in coronary heart disease. Dordrecht/Boston/ London: Kluwer Academic Publishers, 1994a: 275-287.
5. Berg K. Gene-environment interaction: variability gene concept. In: Goldbourt U, de Faire U, Berg K, eds. Genetic factors in coronary heart disease. Dordrecht/Boston/London: Kluwer Academic Publishers, 1994b: 373-383.
6. Berge KE, Berg K. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994: 45: 169-174.
7. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993a: 44: 292-297.
8. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993b: 44: 298-301.
9. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992: 359: 641-644.
10. Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertension 1994: 12 (suppl 4): S3-S10.
11. Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987: 56: 345-348.
12. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994: 87: 211-214.
13. Farhy RD, Ho K-L, Carretero OA, Scicli AG. Kinins mediate the antiproliferative effects of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992: 182: 283-288.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
15. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995: 112: 137-143.
16. Hubert C, Houot A-M, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. J Biol Chem 1991: 266: 15377-15383.
17. Kurtz TW. The ACE of hearts. Nature 1992: 359: 588-589.
18. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995: 91: 270-274.
19. Pelc LR, Gross GJ, Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991: 83: 2048-2056.
20. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990: 86: 1343-1346.
21. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucl Acids Res 1992: 20: 1433.
22. Röschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamt-cholesterins im Serum. Z Klin Chem Klin Biochem 1974: 12: 403-407.
23. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Meth Appl 1993: 3: 120-121.
24. Siervogel RM, Morrison JA, Kelly K, Mellies M, Gartside P, Glueck CJ. Familial hyper-alpha-lipoproteinemia in 26 kind-reds. Clin Genet 1980: 17: 13-25.
25. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Amouyel P, Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993: 341: 991-992.
26. Wahlefeld AW. Triglycerides. Determination after enzymatic hydrolysis. In: Bergmeyer HU, ed. Methods of enzymatic analysis, 2nd edn. New York: Academic Press, 1974: 1831-1835.